Flawed Research Tool Leads To Faulty Medical Findings
[Re: custom-built antibodies in diagnostic tests / treatment research]
By Richard Harris - NPR - September 29, 2016
. . . This is not a quick fix. Tests to validate antibodies are time-consuming and expensive, and sorting through the more than 2 million antibodies on the market today would be a Herculean task.
The National Institutes of Health, which provides $30 billion a year to support biomedical research, is reluctant to insist that scientists use only validated antibodies. . . .
. . . Part of the problem also lies with poor training of young scientists working in university research labs, Freedman says.
GBSI surveyed scientists about their use of antibodies in preparation for the meeting and discovered that
31 percent of young scientists didn't even think it was necessary to validate the antibodies they rely on in their labs, even though bad antibodies could completely invalidate their findings. . . . -
Posts: 48021 | From Tree House | Registered: Jul 2007
| IP: Logged |
Keebler
Honored Contributor (25K+ posts)
Member # 12673
posted
- Hopefully, soon LymeDisease.org to give voice to this on how it might be involved in lyme disease / tick borne disease (TBD) testing. Of course, we already know there is great fault with most testing.
For anyone new to lyme / vector borne infections, testing - as with all things about lyme - is very "political" and an obstacle field for patients:
The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:
The
Lyme Disease Network of New Jersey 907 Pebble Creek Court,
Pennington,
NJ08534USA http://www.lymenet.org/